sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Pharmaceuticals / Erectile Dysfunction Drugs

Erectile Dysfunction Drugs Market by Drug Type (Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others), by Mode of Administration (Oral Medications, Topical Medications, Injections, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

  • Publish On: Oct-2020
  • Total Pages: 225
  • Report Code: FAF-1336
  • Base Year: 2019
  • Format:

Industry Insights

[225+ Pages PDF Report]  Global Erectile Dysfunction Drugs market in 2019 is approximately USD 1,923.3 Million. The market is anticipated to grow at a CAGR of 5.0% and is projected to reach around USD 2,687.6 Million by 2026.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the erectile Dysfunction Drugs market. The report analyzes and declares the historical and current trends analysis of the erectile Dysfunction Drugs market and subsequently recommends the projected trends anticipated to be observed in the erectile Dysfunction Drugs market during the upcoming years.

The Erectile Dysfunction Drugs market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire erectile Dysfunction Drugs market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value in USD Million from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the erectile Dysfunction drug industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the erectile Dysfunction industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the erectile Dysfunction Drugs market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the erectile Dysfunction Drugs industry. The erectile Dysfunction Drugs market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the erectile Dysfunction Drugs sector. Key strategic developments in the erectile DysfunctionDrugs market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the erectile Dysfunction Drugs market are appropriately highlighted in the report.

The Erectile Dysfunction Drugs Market is estimated to develop with a healthy CAGR in upcoming years. Vital signs have wide applications that lead to the growth of the industry.

Key Segment Analysis: Erectile Dysfunction Drugs Market

The study provides a decisive view on the Erectile Dysfunction Drugs market by segmenting the market based on the type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2026.

Based on drug type, the market is segmented Sildenafil Citrate (Viagra), Vardenafil (Levitra/ Staxyn), Tadalafil (Cialis), Udenafil (Zydena), Lodenafil Carbonate (Helleva), Stendra/ Spedra (Avanafil), Mirodenafil (Mvix), and Others

Based on Application the market is segmented into Oral Medications, Topical Medications, Injections, and Others

Based on End-Users the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Sales

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Top Market Players

The report covers a detailed competitive outlook including company profiles of the key participants operating in the global Erectile DysfunctionDrugs market. The key players of Apricus Biosciences, Bayer AG, Cristália, Eli Lilly and Company, Inc., Pfizer, Inc., Dong-A-Pharmaceutical Co., Ltd., S.K. Chemicals Co., Ltd., Vivus, Inc., Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc. and Others

The taxonomy of the Erectile Dysfunction Drugs Market by its scope and segmentation is as follows:

Global Erectile Dysfunction Drugs Market: Drugtype Segment Analysis

  • Sildenafil Citrate (Viagra)
  • Vardenafil (Levitra/ Staxyn)
  • Tadalafil (Cialis)
  • Udenafil (Zydena)
  • Lodenafil Carbonate (Helleva)
  • Stendra/ Spedra (Avanafil)
  • Mirodenafil (Mvix)
  • Others

Global Erectile Dysfunction Drugs Market: Mode of AdministrationSegment Analysis

  • Oral Medications
  • Topical Medications
  • Injections
  • Others

Global Erectile Dysfunction Drugs Market: Distribution ChannelSegment Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Global Erectile Dysfunction Drugs Market: By Region Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a robust research methodology. The triangular process comprises a buoyant mix of exhaustive primary research (focused interviews, questionnaires, and ad-hoc surveys) and extended secondary research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Erectile Dysfunction Drugs Market – Drug Analysis
    1. 2.1. Global Erectile Dysfunction Drugs Market–Drug Overview
    2. 2.2. Global Erectile Dysfunction Drugs Market Share, by Drug, 2019 & 2026 (USD Million)
    3. 2.3. Sildenafil Citrate (Viagra)
      1. 2.3.1. Global Sildenafil Citrate (Viagra)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    4. 2.4. Vardenafil (Levitra/ Staxyn)
      1. 2.4.1. Global Vardenafil (Levitra/ Staxyn)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    5. 2.5. Tadalafil (Cialis)
      1. 2.5.1. Global Tadalafil (Cialis)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    6. 2.6. Udenafil (Zydena)
      1. 2.6.1. Global Udenafil (Zydena)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    7. 2.7. Lodenafil Carbonate (Helleva)
      1. 2.7.1. Global Lodenafil Carbonate (Helleva)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    8. 2.8. Stendra/ Spedra (Avanafil)
      1. 2.8.1. Global Stendra/ Spedra (Avanafil)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    9. 2.9. Mirodenafil (Mvix)
      1. 2.9.1. Global Mirodenafil (Mvix)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    10. 2.10. Others
      1. 2.10.1. Global Others Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
  3. CHAPTER 3. Erectile Dysfunction Drugs Market – Mode of Administration Analysis
    1. 3.1. Global Erectile Dysfunction Drugs Market–Mode of Administration Overview
    2. 3.2. Global Erectile Dysfunction Drugs Market Share, by Mode of Administration, 2019 & 2026 (USD Million)
    3. 3.3. Oral Medications
      1. 3.3.1. Global Oral Medications Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    4. 3.4. Topical Medications
      1. 3.4.1. Global Topical Medications Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    5. 3.5. Injections
      1. 3.5.1. Global Injections Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
    6. 3.6. Others
      1. 3.6.1. Global Others Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
  4. CHAPTER 4. Erectile Dysfunction Drugs Market – Distribution Channel Analysis
    1. 4.1. Global Erectile Dysfunction Drugs Market–Distribution Channel Overview
    2. 4.2. Global Erectile Dysfunction Drugs Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
  5. CHAPTER 5. Erectile Dysfunction Drugs Market – Hospital Pharmacies Analysis
    1. 5.1. Global Erectile Dysfunction Drugs Market–Hospital PharmaciesOverview
    2. 5.2. Global Erectile Dysfunction Drugs Market Share, by Hospital Pharmacies, 2019 & 2026 (USD Million)
  6. CHAPTER 6. Erectile Dysfunction Drugs Market – Retail Pharmacies Analysis
    1. 6.1. Global Erectile Dysfunction Drugs Market–Retail PharmaciesOverview
    2. 6.2. Global Erectile Dysfunction Drugs Market Share, by Retail Pharmacies, 2019 & 2026 (USD Million)
  7. CHAPTER 7. Erectile Dysfunction Drugs Market – Online Sales Analysis
    1. 7.1. Global Erectile Dysfunction Drugs Market–Online SalesOverview
    2. 7.2. Global Erectile Dysfunction Drugs Market Share, by Online Sales, 2019 & 2026 (USD Million)
  8. CHAPTER 8. Erectile Dysfunction Drugs Market – Regional Analysis
    1. 8.1. Global Erectile Dysfunction Drugs MarketRegionalOverview
    2. 8.2. Global Erectile Dysfunction Drugs Market Share, by Region, 2019 & 2026 (Value)
    3. 8.3. North America
      1. 8.3.1. North AmericaErectile Dysfunction Drugs Market size and forecast, 2016-2026
      2. 8.3.2. North AmericaErectile Dysfunction Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 8.3.3. North AmericaErectile Dysfunction Drugs Market, by Drug, 2016-2026
        1. 8.3.3.1. North AmericaErectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
      4. 8.3.4. North AmericaErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026
        1. 8.3.4.1. North AmericaErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
      5. 8.3.5. North AmericaErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026
        1. 8.3.5.1. North AmericaErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 8.3.6. North AmericaErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026
        1. 8.3.6.1. North AmericaErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
      7. 8.3.7. North AmericaErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026
        1. 8.3.7.1. North AmericaErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
      8. 8.3.8. North AmericaErectile Dysfunction Drugs Market, by Online Sales, 2016-2026
        1. 8.3.8.1. North AmericaErectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
      9. 8.3.9. U.S.
        1. 8.3.9.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      10. 8.3.10. Canada
        1. 8.3.10.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 8.4. Europe
      1. 8.4.1. EuropeErectile Dysfunction Drugs Market size and forecast, 2016-2026
      2. 8.4.2. EuropeErectile Dysfunction Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 8.4.3. EuropeErectile Dysfunction Drugs Market, by Drug, 2016-2026
        1. 8.4.3.1. EuropeErectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
      4. 8.4.4. EuropeErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026
        1. 8.4.4.1. EuropeErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
      5. 8.4.5. EuropeErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026
        1. 8.4.5.1. EuropeErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 8.4.6. EuropeErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026
        1. 8.4.6.1. EuropeErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
      7. 8.4.7. EuropeErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026
        1. 8.4.7.1. EuropeErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
      8. 8.4.8. EuropeErectile Dysfunction Drugs Market, by Online Sales, 2016-2026
        1. 8.4.8.1. EuropeErectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
      9. 8.4.9. Germany
        1. 8.4.9.1. Germany Market size and forecast, 2016-2026 (USD Million)
      10. 8.4.10. France
        1. 8.4.10.1. France Market size and forecast, 2016-2026 (USD Million)
      11. 8.4.11. U.K.
        1. 8.4.11.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      12. 8.4.12. Italy
        1. 8.4.12.1. Italy Market size and forecast, 2016-2026 (USD Million)
      13. 8.4.13. Spain
        1. 8.4.13.1. Spain Market size and forecast, 2016-2026 (USD Million)
      14. 8.4.14. Rest of Europe
        1. 8.4.14.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 8.5. Asia Pacific
      1. 8.5.1. Asia PacificErectile Dysfunction Drugs Market size and forecast, 2016-2026
      2. 8.5.2. Asia PacificErectile Dysfunction Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 8.5.3. Asia PacificErectile Dysfunction Drugs Market, by Drug, 2016-2026
        1. 8.5.3.1. Asia PacificErectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
      4. 8.5.4. Asia PacificErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026
        1. 8.5.4.1. Asia PacificErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
      5. 8.5.5. Asia PacificErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026
        1. 8.5.5.1. Asia PacificErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 8.5.6. Asia PacificErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026
        1. 8.5.6.1. Asia PacificErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
      7. 8.5.7. Asia PacificErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026
        1. 8.5.7.1. Asia PacificErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
      8. 8.5.8. Asia PacificErectile Dysfunction Drugs Market, by Online Sales, 2016-2026
        1. 8.5.8.1. Asia PacificErectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
      9. 8.5.9. China
        1. 8.5.9.1. China Market size and forecast, 2016-2026 (USD Million)
      10. 8.5.10. Japan
        1. 8.5.10.1. Japan Market size and forecast, 2016-2026 (USD Million)
      11. 8.5.11. India
        1. 8.5.11.1. India Market size and forecast, 2016-2026 (USD Million)
      12. 8.5.12. South Korea
        1. 8.5.12.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      13. 8.5.13. South-East Asia
        1. 8.5.13.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      14. 8.5.14. Rest of Asia Pacific
        1. 8.5.14.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 8.6. Latin America
      1. 8.6.1. Latin AmericaErectile Dysfunction Drugs Market size and forecast, 2016-2026
      2. 8.6.2. Latin AmericaErectile Dysfunction Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 8.6.3. Latin AmericaErectile Dysfunction Drugs Market, by Drug, 2016-2026
        1. 8.6.3.1. Latin AmericaErectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
      4. 8.6.4. Latin AmericaErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026
        1. 8.6.4.1. Latin AmericaErectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
      5. 8.6.5. Latin AmericaErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026
        1. 8.6.5.1. Latin AmericaErectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 8.6.6. Latin AmericaErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026
        1. 8.6.6.1. Latin AmericaErectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
      7. 8.6.7. Latin AmericaErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026
        1. 8.6.7.1. Latin AmericaErectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
      8. 8.6.8. Latin AmericaErectile Dysfunction Drugs Market, by Online Sales, 2016-2026
        1. 8.6.8.1. Latin AmericaErectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
      9. 8.6.9. Brazil
        1. 8.6.9.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      10. 8.6.10. Mexico
        1. 8.6.10.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      11. 8.6.11. Rest of Latin America
        1. 8.6.11.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 8.7. The Middle-East and Africa
      1. 8.7.1. The Middle-East and Africa Erectile Dysfunction Drugs Market size and forecast, 2016-2026
      2. 8.7.2. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 8.7.3. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Drug, 2016-2026
        1. 8.7.3.1. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
      4. 8.7.4. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026
        1. 8.7.4.1. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
      5. 8.7.5. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026
        1. 8.7.5.1. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 8.7.6. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026
        1. 8.7.6.1. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
      7. 8.7.7. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026
        1. 8.7.7.1. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
      8. 8.7.8. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026
        1. 8.7.8.1. The Middle-East and Africa Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
      9. 8.7.9. GCC Countries
        1. 8.7.9.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      10. 8.7.10. South Africa
        1. 8.7.10.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      11. 8.7.11. Rest of Middle-East Africa
        1. 8.7.11.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  9. CHAPTER 9. Erectile Dysfunction Drugs Market – Competitive Landscape
    1. 9.1. Competitor Market Share – Revenue
    2. 9.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 9.3. Strategic Development
      1. 9.3.1. Acquisitions and Mergers
      2. 9.3.2. New Products
      3. 9.3.3. Research & Development Activities
  10. CHAPTER 10. Company Profiles
    1. 10.1. Apricus Biosciences
      1. 10.1.1. Company Overview
      2. 10.1.2. Apricus Biosciences Revenue and Gross Margin
      3. 10.1.3. Product portfolio
      4. 10.1.4. Recent initiatives
    2. 10.2. Bayer AG
      1. 10.2.1. Company Overview
      2. 10.2.2. Bayer AGRevenue and Gross Margin
      3. 10.2.3. Product portfolio
      4. 10.2.4. Recent initiatives
    3. 10.3. Cristália
      1. 10.3.1. Company Overview
      2. 10.3.2. CristáliaRevenue and Gross Margin
      3. 10.3.3. Product portfolio
      4. 10.3.4. Recent initiatives
    4. 10.4. Eli Lilly and Company, Inc.
      1. 10.4.1. Company Overview
      2. 10.4.2. Eli Lilly and Company, Inc.Revenue and Gross Margin
      3. 10.4.3. Product portfolio
      4. 10.4.4. Recent initiatives
    5. 10.5. Pfizer, Inc.
      1. 10.5.1. Company Overview
      2. 10.5.2. Pfizer, Inc.Revenue and Gross Margin
      3. 10.5.3. Product portfolio
      4. 10.5.4. Recent initiatives
    6. 10.6. Dong-A-Pharmaceutical Co., Ltd.
      1. 10.6.1. Company Overview
      2. 10.6.2. Dong-A-Pharmaceutical Co., Ltd.Revenue and Gross Margin
      3. 10.6.3. Product portfolio
      4. 10.6.4. Recent initiatives
    7. 10.7. S.K. Chemicals Co., Ltd.
      1. 10.7.1. Company Overview
      2. 10.7.2. S.K. Chemicals Co., Ltd.Revenue and Gross Margin
      3. 10.7.3. Product portfolio
      4. 10.7.4. Recent initiatives
    8. 10.8. Vivus, Inc.
      1. 10.8.1. Company Overview
      2. 10.8.2. Vivus, Inc.Revenue and Gross Margin
      3. 10.8.3. Product portfolio
      4. 10.8.4. Recent initiatives
    9. 10.9. Teva Pharmaceutical Industries Ltd.
      1. 10.9.1. Company Overview
      2. 10.9.2. Teva Pharmaceutical Industries Ltd.Revenue and Gross Margin
      3. 10.9.3. Product portfolio
      4. 10.9.4. Recent initiatives
    10. 10.10. Meda Pharmaceuticals, Inc.
      1. 10.10.1. Company Overview
      2. 10.10.2. Meda Pharmaceuticals, Inc.Revenue and Gross Margin
      3. 10.10.3. Product portfolio
      4. 10.10.4. Recent initiatives
    11. 10.11. Others
      1. 10.11.1. Company Overview
      2. 10.11.2. OthersRevenue and Gross Margin
      3. 10.11.3. Product portfolio
      4. 10.11.4. Recent initiatives
  11. CHAPTER 11. Erectile Dysfunction Drugs — Industry Analysis
    1. 11.1. Erectile Dysfunction Drugs Market – Key Trends
      1. 11.1.1. Market Drivers
      2. 11.1.2. Market Restraints
      3. 11.1.3. Market Opportunities
    2. 11.2. Value Chain Analysis
    3. 11.3. Technology Roadmap and Timeline
    4. 11.4. Erectile Dysfunction Drugs Market – Attractiveness Analysis
      1. 11.4.1. By Drug
      2. 11.4.2. By Mode of Administration
      3. 11.4.3. By Distribution Channel
      4. 11.4.4. By Hospital Pharmacies
      5. 11.4.5. By Retail Pharmacies
      6. 11.4.6. By Online Sales
      7. 11.4.7. By Region
  12. CHAPTER 12. Marketing Strategy Analysis, Distributors
    1. 12.1. Marketing Channel
    2. 12.2. Direct Marketing
    3. 12.3. Indirect Marketing
    4. 12.4. Marketing Channel Development Trend
    5. 12.5. Economic/Political Environmental Change
  13. CHAPTER 13. Report Conclusion
  14. CHAPTER 14. Research Approach & Methodology
    1. 14.1. Report Description
    2. 14.2. Research Scope
    3. 14.3. Research Methodology
      1. 14.3.1. Secondary Research
      2. 14.3.2. Primary Research
      3. 14.3.3. Models
        1. 14.3.3.1. Company Share Analysis Model
        2. 14.3.3.2. Revenue Based Modeling
        3. 14.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Erectile Dysfunction Drugs Market, 2016-2026(USD Million)
        FIG. 2 Global Erectile Dysfunction Drugs Market Share, by Drug, 2019 & 2026 (USD Million)
        FIG. 3 Global Sildenafil Citrate (Viagra) Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 4 Global Vardenafil (Levitra/ Staxyn)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 5 Global Tadalafil (Cialis)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 6 Global Udenafil (Zydena)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 7 Global Lodenafil Carbonate (Helleva)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 8 Global Stendra/ Spedra (Avanafil)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 9 Global Mirodenafil (Mvix)Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 10 Global OthersErectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 11 Global Erectile Dysfunction Drugs Market Share, by Mode of Administration, 2019 & 2026 (USD Million)
        FIG. 12 Global Oral Medications Erectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 13 Global Topical MedicationsErectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 14 Global InjectionsErectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 15 Global OthersErectile Dysfunction Drugs Market,2016-2026 (USD Million)
        FIG. 16 Global Erectile Dysfunction Drugs Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
        FIG. 17 Global Erectile Dysfunction Drugs Market Share, by Hospital Pharmacies, 2019 & 2026 (USD Million)
        FIG. 18 Global Erectile Dysfunction Drugs Market Share, by Retail Pharmacies, 2019 & 2026 (USD Million)
        FIG. 19 Global Erectile Dysfunction Drugs Market Share, by Online Sales, 2019 & 2026 (USD Million)
        FIG. 20 Global Erectile Dysfunction Drugs Market Share, by Region, 2019 & 2026
        FIG. 21 North America Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 22 U.S. Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 23 Canada Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 24 Europe Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 25 Germany Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 26 France Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 27 U.K. Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 28 Italy Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 29 Spain Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 30 Rest of Europe Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 31 Asia Pacific Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 32 China Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 33 Japan Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 34 India Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 35 South  Korea Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 36 South-East Asia Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 37 Rest of Asia Pacific Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 38 Latin America Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 39 Brazil Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 40 Mexico Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 41 Rest of Latin America Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 42 The Middle-East and Africa Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 43 GCC Countries Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 44 South Africa Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 45 Rest of Middle-East Africa Erectile Dysfunction Drugs Market, 2016-2026
        FIG. 46 Competitor Market Share – Revenue
        FIG. 47 Apricus Biosciences Revenue and Growth Rate
        FIG. 48 Apricus Biosciences Market Share
        FIG. 49 Bayer AG Revenue and Growth Rate
        FIG. 50 Bayer AG Market Share
        FIG. 51 Cristália Revenue and Growth Rate
        FIG. 52 Cristália Market Share
        FIG. 53 Eli Lilly and Company, Inc. Revenue and Growth Rate
        FIG. 54 Eli Lilly and Company, Inc. Market Share
        FIG. 55 Pfizer, Inc. Revenue and Growth Rate
        FIG. 56 Pfizer, Inc. Market Share
        FIG. 57 Dong-A-Pharmaceutical Co., Ltd. Revenue and Growth Rate
        FIG. 58 Dong-A-Pharmaceutical Co., Ltd. Market Share
        FIG. 59 S.K. Chemicals Co., Ltd. Revenue and Growth Rate
        FIG. 60 S.K. Chemicals Co., Ltd. Market Share
        FIG. 61 Vivus, Inc. Revenue and Growth Rate
        FIG. 62 Vivus, Inc. Market Share
        FIG. 63 Teva Pharmaceutical Industries Ltd. Revenue and Growth Rate
        FIG. 64 Teva Pharmaceutical Industries Ltd. Market Share
        FIG. 65 Meda Pharmaceuticals, Inc. Revenue and Growth Rate
        FIG. 66 Meda Pharmaceuticals, Inc. Market Share
        FIG. 67 Others Revenue and Growth Rate
        FIG. 68 Others Market Share
        FIG. 69 Market Dynamics
        FIG. 70 Global Erectile Dysfunction Drugs – Value Chain Analysis
        FIG. 71 Technology Roadmap and Timeline
        FIG. 72 Market Attractiveness Analysis – By Drug
        FIG. 73 Market Attractiveness Analysis – By Mode of Administration
        FIG. 74 Market Attractiveness Analysis – By Distribution Channel
        FIG. 75 Market Attractiveness Analysis – By Hospital Pharmacies
        FIG. 76 Market Attractiveness Analysis – By Retail Pharmacies
        FIG. 77 Market Attractiveness Analysis – By Online Sales
        FIG. 78 Market Attractiveness Analysis – By Region
        FIG. 79 Market Channel
        FIG. 80 Marketing Channel Development Trend
        FIG. 81 Growth in World Gross Product, 2008-2018
        

        List of Tables

        TABLE 1 Global Erectile Dysfunction Drugs Market, 2018& 2025 (USD Million)
        TABLE 2 Global Erectile Dysfunction Drugs market, by Drug, 2016-2026 (USD Million)
        TABLE 3 Global Erectile Dysfunction Drugs market, by Mode of Administration, 2016-2026 (USD Million)
        TABLE 4 Global Erectile Dysfunction Drugs market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 5 Global Erectile Dysfunction Drugs market, by Hospital Pharmacies, 2016-2026 (USD Million)
        TABLE 6 Global Erectile Dysfunction Drugs market, by Retail Pharmacies, 2016-2026 (USD Million)
        TABLE 7 Global Erectile Dysfunction Drugs market, by Online Sales, 2016-2026 (USD Million)
        TABLE 8 Global Erectile Dysfunction Drugs market, by Region, 2016-2026 (USD Million)
        TABLE 9 North America Erectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
        TABLE 10 North America Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
        TABLE 11 North America Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 12 North America Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
        TABLE 13 North America Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
        TABLE 14 North America Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
        TABLE 15 Europe Erectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
        TABLE 16 Europe Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
        TABLE 17 Europe Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 18 Europe Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
        TABLE 19 Europe Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
        TABLE 20 Europe Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
        TABLE 21 Asia Pacific Erectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
        TABLE 22 Asia Pacific Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
        TABLE 23 Asia Pacific Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 24 Asia Pacific Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
        TABLE 25 Asia Pacific Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
        TABLE 26 Asia Pacific Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
        TABLE 27 Latin America Erectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
        TABLE 28 Latin America Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
        TABLE 29 Latin America Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 30 Latin America Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
        TABLE 31 Latin America Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
        TABLE 32 Latin America Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
        TABLE 33 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Drug, 2016-2026 (USD Million)
        TABLE 34 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Mode of Administration, 2016-2026 (USD Million)
        TABLE 35 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 36 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Hospital Pharmacies, 2016-2026 (USD Million)
        TABLE 37 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Retail Pharmacies, 2016-2026 (USD Million)
        TABLE 38 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Online Sales, 2016-2026 (USD Million)
        TABLE 39 Global Erectile Dysfunction Drugs Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 40 Global Erectile Dysfunction Drugs Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 41 Acquisitions and Mergers
        TABLE 42 New Product/Service Launch
        TABLE 43 Research & Development Activities
        TABLE 44 Market Drivers
        TABLE 45 Market Restraints
        TABLE 46 Market Opportunities
        

Key Insights from Primary Research

  • As per our primary respondents, the global Erectile Dysfunction Drugs market is set to grow annually at a rate of around 5.0%.
  • It was established through primary research that the global Erectile Dysfunction Drugs market was valued at around USD 1,923.3 Million in 2019.
  • The “Sildenafil Citrate (Viagra) category, on the basis of drug Typesegmentation, was the leading revenue-generating category in 2019.
  • On the basis of Route of administration segmentation, the “Oral Route” category holds the largest segment for the global Erectile Dysfunction Drugs market.
  • The patent expiry of leading drugs and increased adoption of alternative treatments are some of the factors responsible for the declining growth of the erectile dysfunction drugs market in the United States.

Key Recommendations from Analysts

  • As per our analysis, the global Erectile DysfunctionDrugsmarket is growing at high CAGR and various end-use industries are aware of this potential market and applications of the Erectile DysfunctionDrugs.
  • Growing at a CAGR around 5.0%, the global Erectile DysfunctionDrugs market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
  • Our analysts have identifiedbreak of Viral Infection COVID 19 is considered  one of the major factor for the growth of the market in the year 2020 and 2021
  • As per our analysis, North Americais expected to account for maximum revenue share, in the target market.

Erectile Dysfunction Drugs Market

Industry Major Market Players

  • Apricus Biosciences
  • Bayer AG
  • Cristália
  • Eli Lilly and Company Inc.
  • Pfizer Inc.
  • Dong-A-Pharmaceutical Co.Ltd.
  • S.K.Chemicals Co.Ltd.
  • Vivus Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Meda Pharmaceuticals Inc.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions